Development and validation of an anion-exchange HPLC method for the determination of fluoride content and radiochemical purity in [18F]NaF

Nuclear Medicine and Biology

Volumn 38, Issue 4, 2011, Pages 605-612

  Li, Chang Chin ^a   Farn, Shiou Shiow ^a,b   Yeh, Yuen Han ^a   Lin, Wuu Jyh ^a   Shen, Lie Hang ^a  

^a INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

18F labeled sodium fluoride, 18F NaF; Anion exchange HPLC; Radioactive detector; Suppressed conductivity detector

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; POTASSIUM; RADIOPHARMACEUTICAL AGENT; SODIUM CARBONATE; SODIUM FLUORIDE F 18; SOLVENT;

ANION EXCHANGE; ARTICLE; BONE EXAMINATION; DIAGNOSTIC ACCURACY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PURIFICATION; QUANTITATIVE ANALYSIS; RADIATION DETECTION; RADIOCHEMISTRY; SCLEROSIS; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; FLUORINE RADIOISOTOPES; LIMIT OF DETECTION; RADIOCHEMISTRY; RADIOPHARMACEUTICALS; SODIUM FLUORIDE; TEMPERATURE;

EID: 79955464783     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.10.008     Document Type: Article

References (21)

1. Even-Sapir E., Metser U., Flusser G., Zuriel L., Kollender Y., Lerman H., et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 2004, 45:272-278.
2. Krüger S., Buck A.K., Mottaghy F.M., Hasenkamp E., Pauls S., Schumann C., et al. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 2009, 36:1807-1812.
3. Even-Sapir E., Mishani E., Flusser G., Metser U. 18F-fluoride positron emission tomography and positron emission tomography/computed tomography. Semin Nucl Med 2007, 37:462-469.
4. Beheshti M., Vali R., Waldenberger P., Fitz F., Nader M., Loidl W., et al. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging 2008, 35:1766-1774.
5. Ovadia D., Metser U., Lievshitz G., Yaniv M., Wientroub S., Even-Sapir E. Back pain in adolescents: assessment with integrated 18F-fluoride positron-emission tomography-computed tomography. J Pediatr Orthop 2007, 27:90-93.
6. Aratake M., Yoshifumi T., Takahashi A., Takeuchi R., Inoue T., Saito T. Evaluation of lesion in a spontaneous osteonecrosis of the knee using 18F-fluoride positron emission tomography. Knee Surg Sports Traumatol Arthrosc 2009, 17:53-59.
7. Laverick S., Bound G., Wong W.L. [18F]-fluoride positron emission tomography for imaging condylar hyperplasia. Br J Oral Maxillofac Surg 2009, 47:196-199.
8. Lim R., Fahey F.H., Drubach L.A., Connolly L.P., Treves S.T. Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain. J Pediatr Orthop 2007, 27:277-282.
9. Schieper C., Nuyts J., Bormans G., et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med 1997, 38:1970-1976.
10. Cook J.R., Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer 2000, 88:2927-2933.
11. Blake G.M., Park-Holoan S.J., Cook G.J.R., Fogelman I. Quantitative studies of bone with the use of F18-fluoride and Tc99m-methylene diphosphonate. Semin Nucl Med 2001, 1:28-49.
12. Grant F.D., Fahey F.H., Packard A.B., Davis R.T., Alavi A., Treves S.T. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med 2008, 49(1):68-78.
13. Even-Sapir E., Metser U., Mishani E., Lievshitz G., Lerman H., Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar BS, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 2006, 47:287-297.
14. Bruns B.R., Tytle T. Skeletal fluorosis: a report of two cases. Orthopedics 1988, 11:1083-1087.
15. Lantz O., Jouvin M.H., DeVernejoul M.C., et al. Fluoride-induced chronic renal failure. Am J Kidney Dis 1987, 10:136-139.
16. Lu Y., Sun Z.R., Wu L.N., et al. Effect of high-fluoride water on intelligence in children. Fluoride 2000, 33:74-78.
17. Nandy S.K., Rajan M.G.R., Soni P.S., Rangarajan V. Production of sterile [F-18] NaF for skeletal PET imaging. BARC (Bhabha Atomic Research Centre) Newslett 2007, 281:16-23. http://www.barc.ernet.in/publications/nl/.
18. The European Pharmacopoeia 6th, Strasbourg, France: the European Directorate for the Quality of Medicine, 2008:1008-1009.
19. The United States Pharmacopeia 32th/The National Formulary 27th (USP32-NF27) Rockville: The United States Pharmacopoeial Convention, 2009:2409.
20. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use: Harmonised Triplicate Guideline on Validation of Analytical Procedures: Methodology, Recommended for Adoption at Step 4 of the ICH Process on November 1996 by the ICH Steering Committee, IFPMA, Switzerland.
21. Douglas A., Skoog F., Holler J., Nieman T.A. Principles of instrumental analysis 1998, Pacific Grove, C.A., USA: Thompson Learning. 5th ed.